dexamethasone sodium phosphate + povidone-iodine + ropivacaine

dexamethasone sodium phosphate + povidone-iodine + ropivacaine is a **combination injection kit product** reported to be marketed under the brand names **ROPIDEX** and **DEXOPIN** and distributed by **Asclemed USA**. The product combines three small-molecule components with distinct roles: dexamethasone sodium phosphate, a water-soluble corticosteroid prodrug of dexamethasone that exerts anti-inflammatory and immunosuppressive effects via glucocorticoid receptor signaling; ropivacaine, an amino amide local anesthetic that blocks voltage-gated sodium channels to produce regional analgesia/anesthesia; and povidone-iodine, a topical antiseptic iodophor that releases iodine and provides broad antimicrobial activity. Based on the supplied context, the kit appears intended for injection-related procedural use rather than representing a novel molecular entity. A notable safety consideration from the literature is that admixture of ropivacaine with dexamethasone sodium phosphate has been reported to cause crystallization, which may be relevant for certain injection applications.

Brand names

ROPIDEXDEXOPIN

Other names

dexamethasone sodium phosphate + povidone-iodine + ropivacaine hydrochloridecombination kit of dexamethasone sodium phosphate + povidone-iodine + ropivacaine